S

Salarius Pharmaceuticals
D

SLRX

4.08000
USD
-0.29
(-6.64%)
مغلق
حجم التداول
3,954
الربح لكل سهم
-188
العائد الربحي
-
P/E
-0
حجم السوق
3,853,919
أصول ذات صلة الأخبار المقالات

العنوان: Salarius Pharmaceuticals Inc

القطاع: Healthcare
الصناعة: Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.